Pharmaceutical companies competing to develop coronavirus vaccines are already working behind the scenes to build the supply chains necessary to deliver their drugs to billions of people as quickly as possible. To meet global demand once a vaccine is approved, a complicated and high-risk supply chain would be put in …
Read More »J&J sews 5-year supply of coronavirus vaccine in more than $ 480 million deal with Emergent
Johnson & Johnson, like all drug makers in the COVID-19 vaccine race, hopes to muster enough manufacturing capacity to rapidly scale production of its vaccine. Now, for a sum of nearly half a trillion dollars, J&J is ready to put his money where his mouth is. J&J and Maryland-based CDMO …
Read More »Moderna targets third quarter for first doses of possible COVID-19 vaccine with Catalent deal
(Reuters) – Moderna Inc (MRNA.O) said Thursday that it was partnering with contract pharmacist Catalent Inc (CTLT.N) to prepare 100 million initial doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which …
Read More »Moderna targets third quarter for first doses of possible COVID-19 vaccine with Catalent deal
(Reuters) – Moderna Inc (MRNA.O) said Thursday that it was partnering with contract pharmacist Catalent Inc (CTLT.N) to prepare 100 million initial doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which …
Read More »Moderna is the latest partner in the coronavirus vaccine for Catalent
Text size Joseph Prezioso / AFP via Getty Images Moderna said it has partnered with Catalent to make the Covid-19 vaccine that the biotech company is about to test in the country’s first major clinical trial. Although the vaccine’s large-scale safety and efficacy have not yet been proven, the urgency …
Read More »